Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review.

ABSTRACT: Advances in scientific understanding have led to novel therapies and improved supportive care for many patients with haematological malignancies. However, these new drugs are often costly, only available at centralised health care facilities, require regular specialist reviews and lengthy treatment regimens. This leads to a significant financial burden. Understanding the impact of financial burden on haematological patients is important to appreciate the urgency of alleviating this systemic issue.

Method

Eligible studies were identified by systematically searching Medline, PsycINFO, CINAHL and Embase. Self-reported data reported in both quantitative and qualitative studies that described the financial burden for patients with haematological malignancies were included. Quality apprai

SUBMITTER: Parker C 

PROVIDER: S-EPMC9221876 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature